Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 572)
Posted On: 02/05/2025 5:19:03 PM
Post# of 154756
Posted By: My69z
In 2024, the Senate Appropriations Committee advanced a report directing NIH to rebalance its RECOVER program to prioritize clinical trials for symptoms that define both long Covid and ME/CFS, such as post-exertional malaise, brain fog, and fatigue.

statnews.com/2025/02/04/rec...
___
Nov. 2024:
The NINDS Institute is also creating what appears to be the first NIH funding opportunities for post-infectious diseases (including ME/CFS, FM, POTS, Lyme, etc.).

*Interestingly, the main target of the virus most linked with ME/CFS – the Epstein-Barr Virus – is B-cells."

healthrising.org/blog/2024/...
___
NIH ME/CFS report Jan. 2025:
" Researchers studied about 13,000 RECOVER participants and found that 4.5% of people who had COVID in the study later developed ME/CFS,...."

recovercovid.org/publicatio...

WHO report was 750m covid cases....













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site